3[1]Knowles MA. What we could do now: molecular pathology of bladder cancer [J]. J Mol Pathol, 2001,54:215- 221.
4[2]Knowles MA.The genetics of transitional cell carcinoma: progress and potential clinical application[J]. BJU Int, 1999, 84(4): 412- 427.
5[3]Cordon-Cardo C. Molecular alterations in bladder cancer[J]. Cancer Surv, 1998,32:115- 131.
6[4]Brandau S, Bohle A. Bladder cancer. I. Molecular and genetic basis of carcinogenesis[J]. Eur Urol, 2001,39(5): 491- 497.
7[5]Jung I, Messing E. Molecular mechanisms and pathways in bladder cancer development and progression [J]. Cancer Control, 2000, 7(4): 325- 334.
8[6]Qureshi KN, Lunec J, Neal DE. Molecular biology changes in bladder cancer: pathways of development and progression[J]. Cancer Surv, 1998,31:77- 97.
9[7]Slaton JW, Benedict WF, Dinney CP. p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy[J]. Urology, 2001, 57(5): 852- 859.
10[8]Koenig F, Jung K, Schnorr D, et al. Urinary markers of malignancy[J]. Clin Chim Acta, 2000,297(1- 2): 191- 205.
